The Current Ratio as of June 2026 (TTM) for Spectrum Pharmaceuticals, Inc. (SPPI) is 2.37

According to Spectrum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.37. This represents a change of 3.49% compared to the average of 2.29 of the last 4 quarters.

Spectrum Pharmaceuticals, Inc. (SPPI) Historical Current Ratio (quarterly & annually)

How has SPPI Current Ratio performed in the past?

The mean historical Current Ratio of Spectrum Pharmaceuticals, Inc. over the last ten years is 2.77. The current 2.37 Current Ratio has changed 8.46% with respect to the historical average. Over the past ten years (40 quarters), SPPI's Current Ratio was at its highest in in the September 2019 quarter at 5.71. The Current Ratio was at its lowest in in the September 2013 quarter at 1.62.

Spectrum Pharmaceuticals, Inc. (SPPI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Spectrum Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Spectrum Pharmaceuticals, Inc. (SPPI) Average Current Ratio

How has SPPI Current Ratio performed in the past?

The current Current Ratio of Spectrum Pharmaceuticals, Inc. (SPPI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Spectrum Pharmaceuticals, Inc. (SPPI) Current Ratio vs. Peers

How is SPPI’s Current Ratio compared to its peers?

Spectrum Pharmaceuticals, Inc.’s Current Ratio is greater than Alaunos Therapeutics, Inc. (1.63), less than CARGO Therapeutics, Inc. Common Stock (12.37), less than Vaccitech plc (6.05), less than Theseus Pharmaceuticals, Inc. (17.79), greater than LakeShore Biopharma Co., Ltd (1.02), less than Zevra Therapeutics, Inc. (4.89), less than Acelyrin, Inc. (18.43), less than LENZ Therapeutics, Inc. (10.40), less than Third Harmonic Bio, Inc. (54.10), greater than Inozyme Pharma, Inc. (2.19),

Build a custom stock screener for Spectrum Pharmaceuticals, Inc. (SPPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spectrum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spectrum Pharmaceuticals, Inc. (SPPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spectrum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.